Anzeige
Mehr »
Login
Freitag, 19.04.2024 Börsentäglich über 12.000 News von 689 internationalen Medien
Goldaktie: Eine Erfolgsgeschichte, die seinesgleichen sucht, startet gerade richtig durch!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
61 Leser
Artikel bewerten:
(0)

Solvay S.A.: Solvay shareholders approve capital increase plan to buy Cytec

  

Brussels, November 17, 2015 --- Solvay today held its Extraordinary Shareholders Meeting with the purpose of obtaining shareholder authorisation for the Board of Directors to proceed with a rights issue of 1.5 billion euros maximum to finance the acquisition of Cytec Industries Inc. in the United States.

Shareholders present at the EGM represented 59.90% of Solvay's share capital and 99.13% voted in favor of such authorisation.
The Board of Directors will decide in due time on the terms and appropriate timing of the intended rights issue.

Details of the voting results as well as a replay of the Shareholders Meeting will be available shortly on Solvay's website, Investors section (http://www.solvay.com/en/investors/shareholders-meeting/2015-AGE-november.html).  

DISCLAIMER

These written materials do not constitute an offer to sell, or a solicitation of offers to purchase or subscribe for, securities in the United States or any other jurisdiction. The securities referred to herein have not been, and will not be, registered under the Securities Act of 1933, as amended, and may not be offered, exercised or sold in the United States absent registration or an applicable exemption from registration requirements. There is no intention to register any offering in the United States or to conduct a public offering of securities in the United States.

The issue, exercise or sale of securities are subject to specific legal or regulatory restrictions in certain jurisdictions. Solvay assumes no responsibility in the event there is a violation by any person of such restrictions.

For further information, please visit this section (http://www.solvay.com/en/investors/cytec-acquisition-financing/index.html)

       Follow us on twitter @SolvayGroup (https://twitter.com/SolvayGroup)

As an international chemical group, Solvay (http://www.solvay.com/)assists industries in finding and implementing ever more responsible and value-creating solutions. Solvay generates 90% of its net sales in activities where it is among the world's top three players. It serves many markets, varying from energy and the environment to automotive and aerospace or electricity and electronics, with one goal: to raise the performance of its clients and improve society's quality of life. The group is headquartered in Brussels, employs about 26,000 people in 52 countries and generated 10.2 billion euros in net sales in 2014. Solvay SA SOLB.BE (http://solb.be/)) is listed on Euronext (https://www.euronext.com/)in Brussels and Paris (Bloomberg: SOLB.BB (http://solb.bb/) - Reuters: SOLB.BR (http://www.reuters.com/finance/stocks/overview'symbol=SOLB.BR)).

Lamia Narcisse (mailto:lamia.narcisse@solvay.com) Caroline Jacobs (mailto:caroline.jacobs@solvay.com) Maria Alcon (mailto:maria.alconhidalgo@solvay.com) Geoffroy Raskin (mailto:geoffroy.raskin@solvay.com) Bisser Alexandrov Mackay (mailto:edward.mackay@solvay.com)
Media Relations Media Relations Investor Relations Investor Relations Investor Relations
+33 1 53 56 59 62 +32 2 264 1530 +32 2 264 1984 +32 2 264 1540 +32 2 264 2142
To read this release in PDF (http://hugin.info/133981/R/1966797/718813.pdf)



This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Solvay S.A. via Globenewswire

HUG#1966797
Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2015 GlobeNewswire (Europe)
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.